Essex Investment Management Co Has Decreased Its Holding in Proqr Thrapeutics N V (PRQR) as Shares Declined; Robecosam Ag Increased Its Ecolab (ECL) Holding by $25.22 Million

Ecolab Inc. (NYSE:ECL) Logo

Essex Investment Management Co Llc decreased its stake in Proqr Thrapeutics N V (PRQR) by 63.42% based on its latest 2018Q3 regulatory filing with the SEC. Essex Investment Management Co Llc sold 52,477 shares as the company’s stock declined 8.47% with the market. The hedge fund held 30,274 shares of the major pharmaceuticals company at the end of 2018Q3, valued at $586,000, down from 82,751 at the end of the previous reported quarter. Essex Investment Management Co Llc who had been investing in Proqr Thrapeutics N V for a number of months, seems to be less bullish one the $573.57 million market cap company. The stock decreased 1.56% or $0.24 during the last trading session, reaching $14.81. About 65,558 shares traded. ProQR Therapeutics N.V. (NASDAQ:PRQR) has risen 478.64% since February 13, 2018 and is uptrending. It has outperformed by 478.64% the S&P500. Some Historical PRQR News: 11/04/2018 – ProQR Announces Annual Meeting of Shareholders; 23/04/2018 – ProQR Therapeutics: Trial on Track to Announce Interim six-Mo Data in 2nd Half; 23/04/2018 – ProQR Therapeutics Access Event Scheduled By LifeSci Advisors; 09/04/2018 ProQR Therapeutics Conference Call Set By Chardan for Apr. 12; 09/05/2018 – ProQR Therapeutics 1Q Loss/Shr EUR0.34; 30/04/2018 – ProQR Announces Conference Presentations for Axiomer┬« RNA Editing Technology and QR-313 for DEB; 23/05/2018 – PROQR APPOINTS Yl-TAO YU, PH.D., TO ITS SCIENTIFIC ADVISORY BOARD; 25/05/2018 – ADAGE CAPITAL PARTNERS REPORTS 5.88 PCT PASSIVE STAKE IN PROQR THERAPEUTICS NV AS OF MAY 17 – SEC FILING; 23/04/2018 – PROQR SAYS ENROLLMENT ON TRACK FOR PHASE QR-110 CLINICAL TRIAL; 23/04/2018 – ProQR Therapeutics: Enrollment Is on Track in the Ongoing Phase 1/2 Clinical Trial of QR-110

Robecosam Ag increased its stake in Ecolab Inc (ECL) by 58.1% based on its latest 2018Q3 regulatory filing with the SEC. Robecosam Ag bought 161,655 shares as the company’s stock rose 0.49% while stock markets declined. The institutional investor held 439,870 shares of the package goods and cosmetics company at the end of 2018Q3, valued at $68.99 million, up from 278,215 at the end of the previous reported quarter. Robecosam Ag who had been investing in Ecolab Inc for a number of months, seems to be bullish on the $46.99 billion market cap company. The stock increased 0.17% or $0.28 during the last trading session, reaching $162.66. About 451,139 shares traded. Ecolab Inc. (NYSE:ECL) has risen 13.74% since February 13, 2018 and is uptrending. It has outperformed by 13.74% the S&P500.

More news for Ecolab Inc. (NYSE:ECL) were recently published by:, which released: “Ecolab (ECL) Acquires Online Training Provider Lobster Ink –” on February 08, 2019.‘s article titled: “How Safe Is Ecolab’s Dividend? – Seeking Alpha” and published on January 21, 2019 is yet another important article.

Since August 27, 2018, it had 0 insider buys, and 7 selling transactions for $17.92 million activity. The insider Mulhere Timothy P sold $1.50 million. HIGGINS ARTHUR J also sold $1.30 million worth of Ecolab Inc. (NYSE:ECL) on Monday, August 27. 9,317 shares were sold by Berger Larry L, worth $1.43M on Monday, September 10. Shares for $6.41 million were sold by BAKER DOUGLAS M JR. On Thursday, September 13 the insider Hickey Michael A sold $5.06 million. BILLER LESLIE S sold 2,811 shares worth $450,884.

Investors sentiment decreased to 0.92 in 2018 Q3. Its down 0.14, from 1.06 in 2018Q2. It dived, as 46 investors sold ECL shares while 313 reduced holdings. 94 funds opened positions while 237 raised stakes. 206.81 million shares or 1.80% less from 210.60 million shares in 2018Q2 were reported. Front Barnett Assoc Limited Liability Company accumulated 7,800 shares or 0.18% of the stock. Lifeplan Group reported 450 shares. Ami Asset Mgmt Corporation holds 251,439 shares or 2.68% of its portfolio. Talara Mgmt Ltd Llc invested in 80,382 shares. Employees Retirement Systems Of Texas reported 11,000 shares. Ubs Asset Management Americas invested in 2.07 million shares or 0% of the stock. Schwartz Counsel reported 100,750 shares or 0.84% of all its holdings. 186,663 are held by Gamco Invsts Inc Et Al. Grace White has invested 0.21% in Ecolab Inc. (NYSE:ECL). Commerzbank Aktiengesellschaft Fi holds 0.16% of its portfolio in Ecolab Inc. (NYSE:ECL) for 105,320 shares. Fiduciary Of The Southwest Tx holds 0.32% or 7,380 shares. Bessemer Inc accumulated 0.03% or 50,943 shares. Fiera Cap reported 938,151 shares. Ny State Common Retirement Fund reported 915,606 shares stake. Timessquare Management Limited Liability Co has 0.56% invested in Ecolab Inc. (NYSE:ECL).

Robecosam Ag, which manages about $2.56B US Long portfolio, decreased its stake in Borgwarner Inc (NYSE:BWA) by 11,000 shares to 282,100 shares, valued at $12.07M in 2018Q3, according to the filing. It also reduced its holding in Valmont Inds Inc (NYSE:VMI) by 45,989 shares in the quarter, leaving it with 101,279 shares, and cut its stake in Deckers Outdoor Corp (NYSE:DECK).

Among 23 analysts covering Ecolab (NYSE:ECL), 9 have Buy rating, 2 Sell and 12 Hold. Therefore 39% are positive. Ecolab had 86 analyst reports since July 30, 2015 according to SRatingsIntel. The firm has “Perform” rating given on Wednesday, November 21 by Oppenheimer. The rating was maintained by BMO Capital Markets on Thursday, November 1 with “Market Perform”. Oppenheimer maintained Ecolab Inc. (NYSE:ECL) on Monday, May 7 with “Buy” rating. On Tuesday, November 3 the stock rating was maintained by Oppenheimer with “Outperform”. The stock of Ecolab Inc. (NYSE:ECL) earned “Overweight” rating by Barclays Capital on Wednesday, October 24. The rating was maintained by Robert W. Baird on Wednesday, October 11 with “Hold”. The rating was maintained by Canaccord Genuity with “Buy” on Thursday, July 27. The rating was maintained by Jefferies with “Hold” on Monday, August 14. Sterne Agee CRT initiated Ecolab Inc. (NYSE:ECL) on Tuesday, March 22 with “Buy” rating. The firm earned “Buy” rating on Tuesday, October 2 by UBS.

More notable recent ProQR Therapeutics N.V. (NASDAQ:PRQR) news were published by: which released: “ProQR to Present at the Evercore ISI HealthConX Conference – GlobeNewswire” on November 20, 2018, also with their article: “ProQR Announces Financial Results for the Second Quarter of 2018 – GlobeNewswire” published on August 08, 2018, published: “ProQR Reaches Agreement with the FDA on Design of Phase 2/3 Pivotal Trial for Sepofarsen (QR-110) for Leber’s Congenital Amaurosis 10 – GlobeNewswire” on January 07, 2019. More interesting news about ProQR Therapeutics N.V. (NASDAQ:PRQR) were released by: and their article: “3 Biotech Stocks That Soared This Week: Are They Buys? – The Motley Fool” published on September 08, 2018 as well as‘s news article titled: “ProQR Therapeutics Added to NASDAQ Biotechnology Index – Nasdaq” with publication date: December 24, 2018.

Analysts await ProQR Therapeutics N.V. (NASDAQ:PRQR) to report earnings on February, 27. They expect $-0.53 earnings per share, down 15.22% or $0.07 from last year’s $-0.46 per share. After $-0.21 actual earnings per share reported by ProQR Therapeutics N.V. for the previous quarter, Wall Street now forecasts 152.38% negative EPS growth.

Among 7 analysts covering ProQR Therapeutics N.V. (NASDAQ:PRQR), 6 have Buy rating, 0 Sell and 1 Hold. Therefore 86% are positive. ProQR Therapeutics N.V. had 10 analyst reports since March 15, 2016 according to SRatingsIntel. The stock has “Outperform” rating by Leerink Swann on Tuesday, September 26. H.C. Wainwright maintained it with “Buy” rating and $4000 target in Tuesday, June 20 report. The firm has “Neutral” rating by Chardan Capital Markets given on Monday, June 20. The firm has “Market Outperform” rating given on Tuesday, March 15 by JMP Securities. Janney Capital initiated the shares of PRQR in report on Thursday, September 29 with “Neutral” rating. H.C. Wainwright maintained ProQR Therapeutics N.V. (NASDAQ:PRQR) rating on Thursday, March 1. H.C. Wainwright has “Buy” rating and $40.0 target.

Essex Investment Management Co Llc, which manages about $740.27 million and $850.92 million US Long portfolio, upped its stake in Arc Document Solutions Inc (NYSE:ARC) by 193,463 shares to 515,965 shares, valued at $1.47M in 2018Q3, according to the filing. It also increased its holding in Barrick Gold Corp (NYSE:ABX) by 270,153 shares in the quarter, for a total of 394,143 shares, and has risen its stake in Identiv Inc (NASDAQ:INVE).

Ecolab Inc. (NYSE:ECL) Institutional Positions Chart